OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advances in targeted therapy for pancreatic cancer
Lin Xing, Linlin Lv, Jiaqi Ren, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115717-115717
Open Access | Times Cited: 15
Lin Xing, Linlin Lv, Jiaqi Ren, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115717-115717
Open Access | Times Cited: 15
Showing 15 citing articles:
Recent Advances in Targeted Cancer Therapy: Are PDCs the Next Generation of ADCs?
Baochen Zhang, Mo Wang, Li Sun, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11469-11487
Closed Access | Times Cited: 8
Baochen Zhang, Mo Wang, Li Sun, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11469-11487
Closed Access | Times Cited: 8
Breaking the stromal barrier in pancreatic cancer: Advances and challenges
Mohana Chakkera, Jeremy B. Foote, Batoul Farran, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 1, pp. 189065-189065
Closed Access | Times Cited: 14
Mohana Chakkera, Jeremy B. Foote, Batoul Farran, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 1, pp. 189065-189065
Closed Access | Times Cited: 14
Inhibitory effects of the combination of rapamycin with gemcitabine plus paclitaxel on the growth of pancreatic cancer tumors
Yuri Jobu, Miki Nishigawa, Kaoru Furihata, et al.
Human Cell (2025) Vol. 38, Iss. 2
Open Access
Yuri Jobu, Miki Nishigawa, Kaoru Furihata, et al.
Human Cell (2025) Vol. 38, Iss. 2
Open Access
Pyrimidine-based dual-target inhibitors targeting epidermal growth factor receptor for overcoming drug resistance in cancer therapy(2006-present)
Yufeng An, Xinya Lv, Shidi Xu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117268-117268
Closed Access
Yufeng An, Xinya Lv, Shidi Xu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117268-117268
Closed Access
Third-line S-1 or FOLFOX treatment in advanced pancreatic cancer who received gemcitabine+nab-paclitaxel and nanoliposomal-irinotecan+5-fluorouracil/leucovorin
Tomomi Sanomachi, Akihiro Ohba, Chigusa Morizane, et al.
Research Square (Research Square) (2025)
Closed Access
Tomomi Sanomachi, Akihiro Ohba, Chigusa Morizane, et al.
Research Square (Research Square) (2025)
Closed Access
Advanced pancreatic cancer treated with camrelizumab combined with apatinib: A case report
Yang Luo, Ting He, Lin Lü, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 2
Closed Access
Yang Luo, Ting He, Lin Lü, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 2
Closed Access
FOSL1 drives the malignant progression of pancreatic cancer cells by regulating cell stemness, metastasis and multidrug efflux system
Xiaolong Liu, Xueyan Zhang, T. X. Zeng, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Xiaolong Liu, Xueyan Zhang, T. X. Zeng, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
mRNA-Based Biomarker Identification for Targeted Therapy Development in Pancreatic Cancer
Saima Firdaus, Rafat Parveen
(2025), pp. 2-2
Open Access
Saima Firdaus, Rafat Parveen
(2025), pp. 2-2
Open Access
Concept of Targeted Drug Conjugate and Its Application in Reversing Drug Resistance
Yuanjiang Wang, Wenqing Xu, Bin Zhang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Yuanjiang Wang, Wenqing Xu, Bin Zhang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Concordance of claudin-18.2 expression in biopsy, resection, and recurrent specimens: implications for zolbetuximab therapy in pancreatic ductal adenocarcinoma
Daisuke Kyuno, Kazuhiko Yanazume, Akira Saitō, et al.
(2025)
Closed Access
Daisuke Kyuno, Kazuhiko Yanazume, Akira Saitō, et al.
(2025)
Closed Access
Landscape of clinical drug development of ADCs used for the pharmacotherapy of cancers: an overview of clinical trial registry data from 2002 to 2022
Wenjing Zhou, Zhiyuan Xu, Shu Liu, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Wenjing Zhou, Zhiyuan Xu, Shu Liu, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
DNA binding studies and in-vitro anticancer studies of novel lanthanide complexes
Yuehong Zhang, Xinshu Li, Kaisu Li, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135048-135048
Closed Access | Times Cited: 2
Yuehong Zhang, Xinshu Li, Kaisu Li, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135048-135048
Closed Access | Times Cited: 2
Editorial for the Special Issue “Advances in the Development of Anticancer Drugs”
Jean Fotie
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 641-641
Open Access | Times Cited: 1
Jean Fotie
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 641-641
Open Access | Times Cited: 1
The efficacy of coaxial percutaneous iodine-125 seed implantation combined with arterial infusion chemotherapy for advanced pancreatic cancer: a randomized clinical trial
Yao Hongxiang, Ying Zhuge, ShiXiang Jin, et al.
International Journal of Radiation Biology (2024) Vol. 100, Iss. 7, pp. 1041-1050
Closed Access | Times Cited: 1
Yao Hongxiang, Ying Zhuge, ShiXiang Jin, et al.
International Journal of Radiation Biology (2024) Vol. 100, Iss. 7, pp. 1041-1050
Closed Access | Times Cited: 1
Inhibitory effects of the combination of rapamycin with gemcitabine plus paclitaxel on the growth of pancreatic cancer tumors
Yuri Jobu, Miki Nishigawa, Kaoru Furihata, et al.
Research Square (Research Square) (2024)
Open Access
Yuri Jobu, Miki Nishigawa, Kaoru Furihata, et al.
Research Square (Research Square) (2024)
Open Access
FOSL1 drives the malignant progression of pancreatic cancer cells by regulating cell stemness, metastasis and multidrug resistance
Shuping Wang, Xiaolong Liu, Xueyan Zhang, et al.
Research Square (Research Square) (2024)
Open Access
Shuping Wang, Xiaolong Liu, Xueyan Zhang, et al.
Research Square (Research Square) (2024)
Open Access
